Navigation Links
UNC researchers receive $100,000 Grand Challenges Exploration Grant to develop male contraceptive
Date:5/10/2010

CHAPEL HILL The University of North Carolina at Chapel Hill has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by James Tsuruta, PhD, and Paul Dayton, PhD, titled "Ultrasound as a long-term, reversible contraceptive."

Tsuruta is an assistant professor in the Laboratories for Reproductive Biology in UNC's Department of Pediatrics. Dayton is associate professor and director of graduate studies in the Department of Biomedical Engineering, which is jointly housed at UNC and N.C. State University.

Tsuruta and Dayton's project is one of 78 grants announced by the Gates Foundation in the fourth funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold and largely unproven ways to improve health in developing countries. The grants were provided to scientists in 18 countries on six continents.

To receive funding, Tsuruta and Dayton showed in a two-page application how their idea falls outside current scientific paradigms and might lead to significant advances in global health. The initiative is highly competitive, receiving almost 2,700 proposals in this round.

"Our long-term goal is to use ultrasound from therapeutic instruments that are commonly found in sports medicine or physical therapy clinics as an inexpensive, long-term, reversible male contraceptive suitable for use in developing to first world countries," said Tsuruta.

"We think this could provide men with up to six months of reliable, low-cost, non-hormonal contraception from a single round of treatment," Tsuruta said. Tsuruta notes that the initial idea to re-examine the effects of ultrasound on sperm production came from another private foundation. "The financial support of the Parsemus Foundation was instrumental in forming a team to study ultrasound's effect on the testis. Our pilot studies would not have been possible without the support of Elaine Lissner (Parsemus), David Sokal (Family Health International), Michael Streicker (Integrated Laboratory Systems) and Michael O'Rand (UNC-CH)."

Tsuruta and Dayton have successfully depleted testicular sperm using therapeutic ultrasound instruments. Once the testis has stopped producing sperm and all "sperm reserves" have been depleted, it is impossible to be fertile. Their Grand Challenges Exploration Grant project is aimed at fine-tuning this technique for maximum effect and safety.

"The winners of these grants show the bold thinking we need to tackle some of the world's greatest health challenges," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "I'm excited about their ideas and look forward to seeing some of these exploratory projects turn into life-saving breakthroughs."


'/>"/>

Contact: Tom Hughes
tahughes@unch.unc.edu
919-966-6047
University of North Carolina School of Medicine
Source:Eurekalert  

Related biology news :

1. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
2. Researchers discover metabolic vulnerability in TB and potential drug target
3. Researchers use entire islands in the Bahamas to test survival of the fittest
4. Researchers discover genetic link between both types of ALS
5. UBC researchers design new biomaterial that mimics muscle elasticity
6. UCLA researchers show how worlds smallest coffee ring may help biosensors detect disease
7. Researchers find melanoma not caused by early UVA light exposure
8. Bugging out: NC State researchers help track wayward pests through mapping
9. Aboriginal hunting and burning increase Australias desert biodiversity, Stanford researchers find
10. Ben-Gurion U researchers isolate microalgal strain that could reduce cholesterol
11. JGH researchers help pinpoint osteoporosis genes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC researchers receive $100,000 Grand Challenges Exploration Grant to develop male contraceptive
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology: